agºÍ¼Ç

À´Ô´£ºÎľߴü £¬×÷Õߣº £¬£º

°¥ £¬à¸¸úÄ㽲࣠£¬ÄãÏþ²»µÃ½ðË®ÇøÓиöºÜÓÐζµÀµÄµØ·½ £¬½ÐË£µÄÏï×Ó¡£Ìýµ½Õâ¸öÃû×Ö £¬ÊDz»ÊǾ;õµÃÓеãÒâ˼ £¿¸ü×ÓÄãÒªÊÇϲ»¶¹ä½Ö³Ô¹¤¾ß £¬»¹ÏëÕÒµãËíµÀµÄ¸ÐÊÜ £¬ßÖ¸öµØ·½¾ø¶Ô²»»áÈÃÄãʧÍû¡£ÄǾ¿¾¹½ðË®ÇøË£µÄÏï×ÓÔÚÄÄÀïÄØ £¿ÎÒ½ñÌì¾ÍÀ´¸øÄãêþ³¶êþ³¶¡£

½ðË®ÇøË£µÄÏï×Ó¾¿¾¹ÔÚÄĹÕ £¿

ÄãÒªÎÊßÖ¸öË£µÄÏï×Ó¾ßÌåÔÚÄÄ¿­ £¬à¸¸úÄ㽲࣠£¬ÂÑÔ¶ÂÑԶûµÃ £¬¾ÍÔÚ½ðË®ÇøµÄºàáé±ß £¬¹Õ¸öÍä¾Íµ½ÁË¡£Ä㿪ͷµ½½ðË®ÇøÄÇÆäÖÐɽ·ËÄÖÜÕÒ £¬ÎÊÎÊ·±ßÂôС³ÔµÄ°¢ÆÅ £¬ËýÃDZȵ¼º½»¹×¼ £¬Ö±ÂéÖ±¾ÍÄÜ´øÄãÕÒµ½ßÖ¸öµØ·½¡£

Õû¸öÏï×Ó²»ËãÌØ±ð´ó £¬ÈýËÄÌõÏï×Ó½»²æ×Å £¬ÅªµÃÏñ¸öÃÔ¹¬í¥×Ó £¬¿ÉÊÇÿÌõÏï×Ó¶¼ÓÐ·×ÆçÑùµÄζµÀ¡£½²ÕæµÄ £¬µÚÒ»´Î¿ËÃâ²»ÁË»á¸ãÂÑÃÔ· £¬µ«Ã»Ê £¬Ïï×ÓÀïÈÈÄÖµÃÂÑ»ðÌÌ £¬Ëæ±ãÒ»¸öµØ·½Í£ÏÂÀ´¶¼ÓиãÍ·¡£

Ë£µÄÏï×ÓÓÐɶºÃ³ÔµÄ £¿

ุúÄã½² £¬½ðË®ÇøßÖ¸öË£µÄÏï×Ó £¬¼òÖ±ÊdzԻõµÄÌìÌá£×î×ÅÃûµÄ¾ÍÊÇÄǼÒÂôÂÝòÏ·ÛµÄÆÌ×Ó £¬Î¶µÀµð¸Ü £¬ÂÑÊǵÄÕý×Ú £¬³ÔÒ»¿ÚÄãÂÑ»á¾õµÃ½Åֺͷ¶¼´ò¾í£¡

ÁíÓÐÒ»¼ÒÂôÏÖ¿¾³ô¶¹¸¯µÄ £¬Ã¿´Î¶¼ÒªÅŶӰëÌì £¬³ôµ½ÂѶ¼·É £¬µ«³Ô½ø×ì°ÍÄãÂѻᷢÃ÷ÏãµÃÒªÃü¡£ÅÔ±ßÁíÓÐÂôÌÇÓÍôÎôεÄ̯×Ó £¬ÀϰåÄïÊÖ½ÅÂéÖ± £¬Ò»¹ø½ÓÒ»¹ø £¬Ìǽ¬¹üµÃÁÁ¾§¾§ £¬³ÔµÃ×ì°Í𤶼²»Ïë˵»°¡£

ÐÑÁúµã£ºÏë³Ôµ½×îÕý×ÚµÄÂÝòÏ·Û £¬×îºÃÏÂÎçÈýµãǰ¿Ë £¬Ã»È»ÂÑÓö¼Ã» £¬ÏüҹʱºòÈ˶àµÃÁ¬ÌõµÊ¶¼ÇÀ²»µ½¡£
Ïà¹ØÍ¼Æ¬

Ë£µÄÏï×ÓÓÐɶºÃÍæµÄ £¿

³Ô±¥ºÈ×ãºó £¬Ïï×ÓÀïÁíÓÐЩÀϹǶ­µê¡¢ÊÖ¹¤ÆÌ £¬Ï²»¶¸ãµãÎÄÒÕ·¶µÄ¿ÉÒÔ¿ËÕÒÕÒ¡£à¸ÉϴξͿ´¼ûÒ»¼ÒÆÌ×ÓÔÚÂôÊÖ¹¤Öñ±à £¬Àϰ廹¾ÍµØ±àÁ˸öСÀº×Ó¸øÎÒ £¬¼ûÂÑÏ¡ÆæµÃºÜ¡£

Ïà¹ØÍ¼Æ¬

ÁíÓÐЩÈËÏ²î³ØÚÏï×ÓÀïÅÄÕÕ £¬ÌرðÊÇÄǼ¸ÃæÍ¿Ñ»Ç½ £¬ÑÕÉ«ÂéÖ±ÏÊÑÞ £¬Ëæ±ãÕ¾Ò»Õ¾¾ÍÊÇ´óƬ¡£¸ü×ÓÄãÈç¹ûÊÇÍíÉÏ¿Ë £¬µÆÁý¹ÒÆðÀ´ £¬Å¯»ÆµÄ¹âÒ»´ò £¬Õû¸öÏï×Ӿ͸ú´©Ô½»ØÃñ¹úí¥×Ó £¬ÀËÂþµÃÂѶ¼µß¡£

Ôõô¿ËµÃÊæÌ¹ £¿

ูÀ¶Ñ £¬×î±ãµ±µÄÕվɴò³µÖ±½Ó¿Ë £¬½ðË®Çø×Ô¼º¾Í²»Ëã´ó £¬³µ·ÑÒ²¸ãÂÑû¼¸¿éÇ®¡£Èç¹ûÄã×Ô¼º¿ª³µ £¬¼Ç×űðÍùÏï×ÓÀï¹Õ £¬ÀïÃæÂÑÕ­ £¬³µ×Ó¿ª½øÈ¥¾ÍÊǰÇÀô¬ £¬Í£¶¼Í£²»À´¡£Í£³µ½¨ÒéÍ£ÔÚÏï×ÓÍâÃæ×¨ÃŵÄÍ£³µ³¡ £¬±ßÉϾÍÓиöÊշѲ»¹óµÄµØ·½¡£

ÐÑÁúµã£ºÖÜÄ©¿ËµÄ»°Ôçµã £¬Ã»È»È˶àµÃ¼·ÂÑë»Ò £¬Á¬Â·¶¼×ß²»ÎÈ¡£
Ïà¹ØÍ¼Æ¬

×ܽ᣺ˣµÄÏï×ÓÖµµÃ¿ËÂ𠣿

½²µ½ÕâÀï £¬Äã¿ÉÄÜ»¹ÔÚÎÊ £¬ÄǾ¿¾¹½ðË®ÇøË£µÄÏï×ÓÖµ²»ÖµµÃÒ»¿Ë £¿à¸¸úÄã½² £¬Ã»ÐÅÄã¿ËÊÔÏÂ×Ó £¬³Ô³ÔºÈºÈÍæÍæÅÄÕÕ £¬ÂѺùý¡£Òªº¦ÊÇßÖ¸öµØ·½½ÓµØÆø £¬Ã»ÄÇôÉÌÒµ»¯ £¬ÄÜÕÒµ½²»ÉÙԭ֭ԭζµÄ¹¤¾ß¡£


ÄǾ¿¾¹½ðË®ÇøË£µÄÏï×ÓÔÚÄÄÀï £¿ÂѼòµ¥£¡¾ÍÔÚ½ðË®ÇøÖÐɽ·ËÄÖÜ £¬³ÔºÈÍæÀÖ¶¼ÆëÈ« £¬¿ËÒ»´Î×¼Éá²»µÃ×ß¡£

½ðË®ÇøË£µÄÏï×Ó, ÀϽÖÃÀʳ, Ïï×Ó¹¥ÂÔ, ÂÝòÏ·Û, ÂÃÓÎСÖÚÍÆ¼ö

¡¶¹þ¶û±õ³ÇÖдåÍÆÄõê¿ì²Í¡·

¡°ÄêÇáÒâζ×ÅÄã¸Õ¸ÕѧÍê×îÇ°ÑØµÄ¼¼Êõ¼Ü¹¹ £¬Ë¼Î¬»¹Ã»Óб»¾Éʱ´úµÄÂß¼­Ëù¹Ì»¯¡£¡±Ò»Î»¹è¹È·çͶºÏ×ÊÈËÈç´Ë½âÊÍ×ʱ¾µÄÂß¼­¡£ÔÚAIÕâ¸öÒÔTransformer¼Ü¹¹ÑݽøÎªÀï³Ì±®µÄÁìÓò £¬¼¼Êõµü´úµÄËÙ¶ÈÈá°¾­Ñ顱µÄ±£ÖÊÆÚ´ó·ùËõ¶Ì¡£°ëÄêÇ°ÕÆÎյļ¼Êõ £¬½ñÌì¿ÉÄÜÒѹýʱ¡£

Ïà¹ØÍ¼Æ¬

¡¶ÏåÔ«Âô‹HʲôµØ·½×î¶à¡·

1ÔÂ21ÈÕ £¬È«Çò×ʱ¾Êг¡µÄÄ¿¹â¾Û½¹ÔÚÁËÒ»×éÊý¾ÝÉÏ¡£»Æ½ð¼Û¸ñ×ÔÉÏÖÜÁ¬ÐøÉÏÕÇºó £¬ÓÚ½ñÈÕÔÙ´ÎË¢ÐÂÀúÊ·¼Í¼¡£

¡¶ÎߺþÍå›bСºúÍ¬ÍÆÄõêÔÚÄÄ¡·

ÓÐÐÐÒµÈËʿָ³ö £¬2026Ä꿪ÄêµÄ˽ļ¿¯ÐÐÈȳ± £¬ÊµÖÊÉÏÊÇ¡°ÐÐÇ黨ŝ¡ª¾»ÖµÐÞ¸´¡ª¹æÄ£À©ÈÝ¡ª¿¯Ðл𱬡±ÕâÒ»Õý·´ÏìÁ´Ìõ¼ÓËÙÔËתµÄ¼¯ÖÐÌåÏÖ¡£

¡¶ÄϲýݸʽЧÀÍ498ÌײÍÄÚÈÝ¡·

¶øËæ×ÅSacituzumab tirumotecanµÄ¶àÏîIIIÆÚÁÙ´²ÊµÑéÔÚ2025ÄêÆô¶¯ £¬»ðÈȵÄTROP2 ADCÊг¡·ºÆðÁËеıêÁ¿¡£×÷ΪØÊºóÕß £¬½èÖúĬɳ¶«Ç¿´óµÄ¿¹Ö×ÁöÒ©ÎïÁÙ´²¿ª·¢¾­Ñé £¬sacituzumab tirumotecanÓÐÁËÔÚ±ÊÖ±ÁìÓòÍäµÀ³¬³µµÄ¿ÉÄÜÐÔ¡£ÔÚÕâ¸öÀú³ÌÖÐ £¬±£´æÁËsacituzumab tirumotecanÖйúÊг¡È¨ÒæµÄ¿ÆÂײ©Ì© £¬Ò²ÓÉ´Ë»ñµÃÁËÍÆ¶¯Êг¡»¨Ñù¸Ä±äµÄÁ¦Á¿¡£

ÍøÕ¾µØÍ¼